What Does IDEXX Laboratories’ Debt Look Like?

Over the past three months, shares of IDEXX Laboratories Inc. (NASDAQ:IDXX) increased by 2.13%. Before having a look…

Over the past three months, shares of IDEXX Laboratories Inc. (NASDAQ:IDXX) increased by 2.13%. Before having a look at the importance of debt, let’s look at how much debt IDEXX Laboratories has.

IDEXX Laboratories Debt

Based on IDEXX Laboratories’s balance sheet as of February 16, 2023, long-term debt is at $694.39 million and current debt is at $653.98 million, amounting to $1.35 billion in total debt. Adjusted for $112.55 million in cash-equivalents, the company’s net debt is at $1.24 billion.

Let’s define some of the terms we used in the paragraph above. Current debt is the portion of a company’s debt which is due within 1 year, while long-term debt is the portion due in more than 1 year. Cash equivalents includes cash and any liquid securities with maturity periods of 90 days or less. Total debt equals current debt plus long-term debt minus cash equivalents.

To understand the degree of financial leverage a company has, investors look at the debt ratio. Considering IDEXX Laboratories’s $2.75 billion in total assets, the debt-ratio is at 0.49. As a rule of thumb, a debt-ratio more than 1 indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself at risk for default, if interest rates were to increase. However, debt-ratios vary widely across different industries. A debt ratio of 40% might be higher for one industry, but average for another.

debt_fig

Importance of Debt

Besides equity, debt is an important factor in the capital structure of a company, and contributes to its growth. Due to its lower financing cost compared to equity, it becomes an attractive option for executives trying to raise capital.

However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Equity owners can keep excess profit, generated from the debt capital, when companies use the debt capital for its business operations.

Looking for stocks with low debt-to-equity ratios? Check out Benzinga Pro, a market research platform which provides investors with near-instantaneous access to dozens of stock metrics – including debt-to-equity ratio. Click here to learn more.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Annji Pharmaceutical Has Entered Into An Exclusive License Agreement With Avenue Therapeutics For AJ201 For Spinal And Bulbar Muscular Atrophy, Also Known As Kennedy’s Disease; Upfront Payment Of $3M, Milestone Payments Of Upto $250M

The deal covers the U.S., Canada, European Union, Great Britain, And Israel. Avenue will also issue 831,618 shares as equity upfront and additional shares upon the achievement of a clinical milestone, aggregating

ATXI

Read More

Clay Court Takeover: TNT Sports To Bring French Open To US Fans Starting 2025

Starting in 2025, Warner Bros. Discovery through TNT Sports, will exclusively broadcast the Roland-Garros French Open in the U.S. The 10-year deal extends WBD's reach in tennis, aligning with its ambition to expand premium sports content, covering nearly 900 matches across TNT, TBS, and truTV, plus digital platforms like Bleacher Report.

DIS